NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
17.34
+0.40 (2.36%)
Jan 22, 2026, 1:03 PM EST - Market open
NeuroPace Stock Forecast
Stock Price Forecast
The 7 analysts that cover NeuroPace stock have a consensus rating of "Strong Buy" and an average price target of $18, which forecasts a 3.81% increase in the stock price over the next year. The lowest target is $16 and the highest is $22.
Price Target: $18 (+3.81%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 16, 2025.
Analyst Ratings
The average analyst rating for NeuroPace stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $18 → $22 | Strong Buy | Maintains | $18 → $22 | +26.87% | Dec 16, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $18 → $20 | Buy | Maintains | $18 → $20 | +15.34% | Dec 10, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $16 → $18 | Buy | Maintains | $16 → $18 | +3.81% | Nov 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | -7.73% | Nov 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $17 → $15 | Buy | Maintains | $17 → $15 | -13.49% | Aug 13, 2025 |
Financial Forecast
Revenue This Year
99.74M
from 79.91M
Increased by 24.82%
Revenue Next Year
100.50M
from 99.74M
Increased by 0.77%
EPS This Year
-0.78
from -0.93
EPS Next Year
-0.65
from -0.78
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 102.9M | 105.4M | ||||
| Avg | 99.7M | 100.5M | ||||
| Low | 95.1M | 94.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 28.8% | 5.7% | ||||
| Avg | 24.8% | 0.8% | ||||
| Low | 19.0% | -4.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.76 | -0.46 | ||||
| Avg | -0.78 | -0.65 | ||||
| Low | -0.78 | -0.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.